$1.24
-0.04-3.13%
At close: Aug 28, 5:00 PM EST
$1.24
N/A
After Hours: Aug 28, 7:22 PM EST

Nanoviricides (NNVC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.09 | $-0.10 | $-0.16 | — |
| Actual | $-0.09 | $-0.11 | $-0.10 | $-0.13 |
| Surprise | 0.00% | -10.0% | +37.5% | — |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.09 | $-0.09 | $-0.11 | $-0.12 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | May 15, 2026 | $-0.09 | $-0.09 | 0.00 % |
| Q2 | Feb 17, 2026 | $-0.11 | $-0.10 | -10.0 % |
| Q1 | Nov 14, 2025 | $-0.10 | $-0.16 | 37.5 % |
| Q3 | May 15, 2024 | $-0.16 | $-0.19 | 15.8 % |